Study on Muscle Loss in COPD Patients
Author Information
Author(s): Nicholas S Hopkinson, Rachel C Tennant, Mark J Dayer, Elisabeth B Swallow, Trevor T Hansel, John Moxham, Michael I Polkey
Primary Institution: Royal Brompton Hospital
Hypothesis
The study investigates the impact of disease severity, exacerbation frequency, and corticosteroid treatment on muscle strength and fat free mass in COPD patients.
Conclusion
The decline in fat free mass in COPD is linked to worse lung function, continued smoking, and frequent exacerbations.
Supporting Evidence
- QMVC fell from 34.8 kg to 33.3 kg (p = 0.04).
- Decline in fat free mass was greater in patients with frequent exacerbations.
- Patients who stopped smoking experienced an increase in fat free mass.
Takeaway
This study shows that people with COPD can lose muscle strength and mass over time, especially if they have more severe disease or keep smoking.
Methodology
Patients with stable COPD were studied at baseline and one year later, measuring fat free mass and quadriceps strength.
Potential Biases
Potential bias due to exclusion of patients with significant comorbidities and logistical issues affecting follow-up.
Limitations
Follow-up data was not available for all patients, which could introduce bias.
Participant Demographics
34% female, mean age 62 years, mean cigarette exposure 47 pack years.
Statistical Information
P-Value
0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website